Susanne P.
- Country
- Germany
- Department
- 1607:Augenklinik
Research Overview
- Phase 3 Randomized Quadruple-Masked Placebo-Controlled Trial of Batoclimab in Active Thyroid Eye Disease
- Evaluation of Efgartigimod Alfa PH20 SC Efficacy and Safety in Adults with Thyroid Eye Disease: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study
- Phase 3 Randomized Quadruple-Masked Placebo-Controlled Trial of Batoclimab in Active Thyroid Eye Disease Patients
Data & Insights
Has run more than one trial at 12 of 85 partner sites.
Specializations
Ophthalmology Focus
The investigator specializes in Thyroid Eye Disease (TED), focusing on advanced therapeutic approaches for this complex ophthalmic condition.
- Orbital inflammatory disorders
- Eye muscle dysfunction
- Proptosis management
Their expertise extends to evaluating novel biological treatments for ocular manifestations of thyroid disorders.
Immunological Research
Active involvement in studying immunomodulatory therapies and their applications in autoimmune eye conditions.
- Antibody-based treatments
- Subcutaneous administration protocols
- Long-term therapeutic outcomes
The investigator focuses on evaluating innovative biological agents for autoimmune eye disorders.
Clinical Therapeutics
Expertise in therapeutic development with particular attention to safety and efficacy assessment of new treatments.
- Treatment response monitoring
- Drug tolerance evaluation
- Long-term patient outcomes
Their work encompasses the evaluation of various administration routes and dosing protocols for ophthalmic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.